{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:16:10Z","timestamp":1790972170830,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-07908-0","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:09:30Z","timestamp":1744002570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A structural and mechanistic model for BSEP dysfunction in PFIC2 cholestatic disease"],"prefix":"10.1038","volume":"8","author":[{"given":"Cl\u00e9mence","family":"Gruget","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-7433","authenticated-orcid":false,"given":"Bharat G.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8633-3313","authenticated-orcid":false,"given":"Jonathan M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"7908_CR1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.clinre.2012.06.006","volume":"36","author":"R Kubitz","year":"2012","unstructured":"Kubitz, R., Droge, C., Stindt, J., Weissenberger, K. & Haussinger, D. The bile salt export pump (BSEP) in health and disease. Clin. Res. Hepatol. Gastroenterol. 36, 536\u2013553 (2012).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"7908_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1172\/JCI0215968","volume":"110","author":"L Wang","year":"2002","unstructured":"Wang, L., Soroka, C. J. & Boyer, J. L. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II. J. Clin. Investig. 110, 965\u2013972 (2002).","journal-title":"J. Clin. Investig."},{"key":"7908_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1517\/14728222.2016.1102889","volume":"20","author":"A Telbisz","year":"2016","unstructured":"Telbisz, A. & Homolya, L. Recent advances in the exploration of the bile salt export pump (BSEP\/ABCB11) function. Expert Opin. Ther. Targets 20, 501\u2013514 (2016).","journal-title":"Expert Opin. Ther. Targets"},{"key":"7908_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2013.05.001","volume":"37","author":"C. J Soroka","year":"2014","unstructured":"Soroka, C. J. & Boyer, J. L. Biosynthesis and trafficking of the bile salt export pump, BSEP: Therapeutic implications of BSEP mutations. Mol. Asp. Med. 37, 3\u201314 (2014).","journal-title":"Mol. Asp. Med."},{"key":"7908_CR5","doi-asserted-by":"crossref","unstructured":"Lai, Y. in Transporters in Drug Discovery and Development. 327\u2013352 (Woodhead Publishing, 2013).","DOI":"10.1533\/9781908818287.327"},{"key":"7908_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","volume":"4","author":"A Srivastava","year":"2014","unstructured":"Srivastava, A. Progressive familial intrahepatic cholestasis. J. Clin. Exp. Hepatol. 4, 25\u201336 (2014).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"7908_CR7","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/hep.23539","volume":"51","author":"A Davit-Spraul","year":"2010","unstructured":"Davit-Spraul, A. et al. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 51, 1645\u20131655 (2010).","journal-title":"Hepatology"},{"key":"7908_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-4-1","volume":"4","author":"A Davit-Spraul","year":"2009","unstructured":"Davit-Spraul, A., Gonzales, E., Baussan, C. & Jacquemin, E. Progressive familial intrahepatic cholestasis. Orphanet J. Rare Dis. 4, 1 (2009).","journal-title":"Orphanet J. Rare Dis."},{"key":"7908_CR9","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1021\/acs.chemrev.0c00659","volume":"121","author":"T Kroll","year":"2021","unstructured":"Kroll, T., Prescher, M., Smits, S. H. J. & Schmitt, L. Structure and function of hepatobiliary ATP binding cassette transporters. Chem. Rev. 121, 5240\u20135288 (2021).","journal-title":"Chem. Rev."},{"key":"7908_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","volume":"134","author":"S. S Strautnieks","year":"2008","unstructured":"Strautnieks, S. S. et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 134, 1203\u20131214.e1208 (2008).","journal-title":"Gastroenterology"},{"key":"7908_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2017.02.020","volume":"136","author":"V Vauthier","year":"2017","unstructured":"Vauthier, V., Housset, C. & Falgui\u00e8res, T. Targeted pharmacotherapies for defective ABC transporters. Biochem. Pharm. 136, 1\u201311 (2017).","journal-title":"Biochem. Pharm."},{"key":"7908_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","volume":"73","author":"D. B. E van Wessel","year":"2020","unstructured":"van Wessel, D. B. E. et al. Genotype correlates with the natural history of severe bile salt export pump deficiency. J. Hepatol. 73, 84\u201393 (2020).","journal-title":"J. Hepatol."},{"key":"7908_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","volume":"17","author":"C Lang","year":"2007","unstructured":"Lang, C. et al. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet. Genom. 17, 47\u201360 (2007).","journal-title":"Pharmacogenet. Genom."},{"key":"7908_CR14","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/apt.16118","volume":"52","author":"J. S Nayagam","year":"2020","unstructured":"Nayagam, J. S., Williamson, C., Joshi, D. & Thompson, R. J. Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1. Aliment. Pharm. Therapeut. 52, 1628\u20131639 (2020).","journal-title":"Aliment. Pharm. Therapeut."},{"key":"7908_CR15","doi-asserted-by":"publisher","unstructured":"van Tung, N. et al. The role of p.Val444Ala variant in the ABCB11 gene and susceptibility to biliary atresia in Vietnamese patients. Medicine 100. https:\/\/doi.org\/10.1097\/MD.0000000000028011 (2021).","DOI":"10.1097\/MD.0000000000028011"},{"key":"7908_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3892\/mmr.2014.2645","volume":"11","author":"S Pan","year":"2015","unstructured":"Pan, S. et al. Variations of ABCB4 and ABCB11 genes are associated with primary intrahepatic stones. Mol. Med. Rep. 11, 434\u2013446 (2015).","journal-title":"Mol. Med. Rep."},{"key":"7908_CR17","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1074\/jbc.M307363200","volume":"279","author":"A Figge","year":"2004","unstructured":"Figge, A. et al. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis. J. Biol. Chem. 279, 2790\u20132799 (2004).","journal-title":"J. Biol. Chem."},{"key":"7908_CR18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/liv.14423","volume":"40","author":"C. D Fuchs","year":"2020","unstructured":"Fuchs, C. D. et al. Absence of Bsep\/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice. Liver Int. 40, 1366\u20131377 (2020).","journal-title":"Liver Int"},{"key":"7908_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00535-015-1148-y","volume":"51","author":"K Okushin","year":"2016","unstructured":"Okushin, K. et al. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease. J. Gastroenterol. 51, 808\u2013818 (2016).","journal-title":"J. Gastroenterol."},{"key":"7908_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/hep.22683","volume":"49","author":"J. A Byrne","year":"2009","unstructured":"Byrne, J. A. et al. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 49, 553\u2013567 (2009).","journal-title":"Hepatology"},{"key":"7908_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/hep.20627","volume":"41","author":"H Hayashi","year":"2005","unstructured":"Hayashi, H., Takada, T., Suzuki, H., Akita, H. & Sugiyama, Y. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP\/ABCB11. Hepatology 41, 916\u2013924 (2005).","journal-title":"Hepatology"},{"key":"7908_CR22","doi-asserted-by":"publisher","first-page":"C1709","DOI":"10.1152\/ajpcell.00327.2007","volume":"293","author":"P Lam","year":"2007","unstructured":"Lam, P. et al. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep\/Abcb11) correlate with severity of cholestatic diseases. Am. J. Physiol. Cell Physiol. 293, C1709\u2013C1716 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"7908_CR23","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/hep.22499","volume":"48","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial Intrahepatic cholestasis type II. Hepatology 48, 1558\u20131569 (2008).","journal-title":"Hepatology"},{"key":"7908_CR24","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/hep.21630","volume":"45","author":"H Hayashi","year":"2007","unstructured":"Hayashi, H. & Sugiyama, Y. 4-Phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps. Hepatology 45, 1506\u20131516 (2007).","journal-title":"Hepatology"},{"key":"7908_CR25","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1016\/j.bmc.2012.03.016","volume":"20","author":"T Misawa","year":"2012","unstructured":"Misawa, T., Hayashi, H., Sugiyama, Y. & Hashimoto, Y. Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2. Bioorg. Med. Chem. 20, 2940\u20132949 (2012).","journal-title":"Bioorg. Med. Chem."},{"key":"7908_CR26","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/liv.14839","volume":"41","author":"A Ben Saad","year":"2021","unstructured":"Ben Saad, A. et al. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants. Liver Int. 41, 1344\u20131357 (2021).","journal-title":"Liver Int"},{"key":"7908_CR27","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1016\/S0168-8278(22)01366-6","volume":"77","author":"E Mareux","year":"2022","unstructured":"Mareux, E. et al. In vitro rescue of the bile acid transport function of some ABCB11 variants by CFTR potentiators: a targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2. J. Hepatol. 77, S521\u2013S522 (2022).","journal-title":"J. Hepatol."},{"key":"7908_CR28","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1111\/liv.14518","volume":"40","author":"E Mareux","year":"2020","unstructured":"Mareux, E. et al. Functional rescue of an ABCB11 mutant by ivacaftor: a new targeted pharmacotherapy approach in bile salt export pump deficiency. Liver Int 40, 1917\u20131925 (2020).","journal-title":"Liver Int"},{"key":"7908_CR29","doi-asserted-by":"publisher","unstructured":"Gordo-Gilart, R., Andueza, S., Hierro, L., Jara, P. & Alvarez, L. Functional rescue of trafficking-impaired ABCB4 mutants by chemical chaperones. PLoS ONE 11. https:\/\/doi.org\/10.1371\/journal.pone.0150098 (2016).","DOI":"10.1371\/journal.pone.0150098"},{"key":"7908_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jhep.2012.04.017","volume":"57","author":"E Gonzales","year":"2012","unstructured":"Gonzales, E. et al. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2. J. Hepatol. 57, 695\u2013698 (2012).","journal-title":"J. Hepatol."},{"key":"7908_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/hep.27767","volume":"62","author":"E Gonzales","year":"2015","unstructured":"Gonzales, E. et al. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: evidence for improvement of cholestasis with 4-phenylbutyrate. Hepatology 62, 558\u2013566 (2015).","journal-title":"Hepatology"},{"key":"7908_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.tibs.2019.01.003","volume":"44","author":"A Stein","year":"2019","unstructured":"Stein, A., Fowler, D. M., Hartmann-Petersen, R. & Lindorff-Larsen, K. Biophysical and mechanistic models for disease-causing protein variants. Trends Biochem. Sci. 44, 575\u2013588 (2019).","journal-title":"Trends Biochem. Sci."},{"key":"7908_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ab.2004.04.031","volume":"332","author":"M. C Lo","year":"2004","unstructured":"Lo, M. C. et al. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal. Biochem. 332, 153\u2013159 (2004).","journal-title":"Anal. Biochem."},{"key":"7908_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/bip.360310111","volume":"31","author":"G. V Semisotnov","year":"1991","unstructured":"Semisotnov, G. V. et al. Study of the \u201cmolten globule\u201d intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 31, 119\u2013128 (1991).","journal-title":"Biopolymers"},{"key":"7908_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/2472555219877183","volume":"25","author":"M. J Henderson","year":"2020","unstructured":"Henderson, M. J., Holbert, M. A., Simeonov, A. & Kallal, L. A. High-throughput cellular thermal shift assays in research and drug discovery. SLAS Discov. 25, 137\u2013147 (2020).","journal-title":"SLAS Discov."},{"key":"7908_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27834-y","volume":"8","author":"N. J Martinez","year":"2018","unstructured":"Martinez, N. J. et al. A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase. Sci. Rep. 8, 9472 (2018).","journal-title":"Sci. Rep."},{"key":"7908_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84\u201387 (2013).","journal-title":"Science"},{"key":"7908_CR38","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1021\/acsmedchemlett.1c00276","volume":"12","author":"J. D Mortison","year":"2021","unstructured":"Mortison, J. D. et al. Rapid Evaluation of Small Molecule Cellular Target Engagement with a Luminescent Thermal Shift Assay. ACS Med.Chem. Lett. 12, 1288\u20131294 (2021).","journal-title":"ACS Med.Chem. Lett."},{"key":"7908_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-0716-3397-7_11","volume":"2706","author":"S Ramachandran","year":"2023","unstructured":"Ramachandran, S. et al. Chemogenomics, methods and protocols. Methods Mol. Biol. 2706, 149\u2013165 (2023).","journal-title":"Methods Mol. Biol."},{"key":"7908_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-0716-1665-9_2","volume":"2365","author":"T. W Sanchez","year":"2021","unstructured":"Sanchez, T. W. et al. Targeted protein degradation, methods and protocols. Methods Mol. Biol. 2365, 21\u201341 (2021).","journal-title":"Methods Mol. Biol."},{"key":"7908_CR41","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1021\/acschembio.2c00334","volume":"17","author":"T. W Sanchez","year":"2022","unstructured":"Sanchez, T. W. et al. Real-time cellular thermal shift assay to monitor target engagement. ACS Chem. Biol. 17, 2471\u20132482 (2022).","journal-title":"ACS Chem. Biol."},{"key":"7908_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/gut.2008.159541","volume":"58","author":"P. H Dixon","year":"2009","unstructured":"Dixon, P. H. et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 58, 537\u2013544 (2009).","journal-title":"Gut"},{"key":"7908_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.gastro.2003.11.003","volume":"126","author":"R Kubitz","year":"2004","unstructured":"Kubitz, R., S\u00fctfels, G., K\u00fchlkamp, T., K\u00f6lling, R. & H\u00e4ussinger, D. Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. Gastroenterology 126, 541\u2013553 (2004).","journal-title":"Gastroenterology"},{"key":"7908_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3748\/wjg.14.38","volume":"14","author":"Y Meier","year":"2008","unstructured":"Meier, Y. et al. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. World J. Gastroenterol. 14, 38\u201345 (2008).","journal-title":"World J. Gastroenterol."},{"key":"7908_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43109-1","volume":"14","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Structural basis of bile salt extrusion and small-molecule inhibition in human BSEP. Nat. Commun. 14, 7296 (2023).","journal-title":"Nat. Commun."},{"key":"7908_CR46","doi-asserted-by":"publisher","first-page":"12402","DOI":"10.1073\/pnas.1511308112","volume":"112","author":"J Danielsson","year":"2015","unstructured":"Danielsson, J. et al. Thermodynamics of protein destabilization in live cells. Proc. Natl. Acad. Sci. USA 112, 12402\u201312407 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7908_CR47","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","volume":"10","author":"M Lopes-Pacheco","year":"2019","unstructured":"Lopes-Pacheco, M. CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine. Front. Pharm. 10, 1662 (2019).","journal-title":"Front. Pharm."},{"key":"7908_CR48","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/nprot.2014.173","volume":"9","author":"A Goehring","year":"2014","unstructured":"Goehring, A. et al. Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat. Protoc. 9, 2574\u20132585 (2014).","journal-title":"Nat. Protoc."},{"key":"7908_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"7908_CR50","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"T. I Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D. Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"7908_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"E. C Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: Tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."},{"key":"7908_CR52","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"7908_CR53","doi-asserted-by":"publisher","DOI":"10.5061\/dryad.cnp5hqcgd","author":"J Moore","year":"2025","unstructured":"Moore, J., Gruget, C. & Reddy, B. CETSA, nanoDSF and kinetic data for the bile salt export pump and patient variants reported. Dryad Digit. Repos. https:\/\/doi.org\/10.5061\/dryad.cnp5hqcgd (2025).","journal-title":"Dryad Digit. Repos."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07908-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07908-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07908-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:09:32Z","timestamp":1744002572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07908-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7908"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-07908-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.29.605648","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: J.M.M. and B.G.R. are employees of Rectify Pharmaceuticals and receive salary and equity compensation. C.G. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"531"}}